Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc.

Neurotech Pharmaceuticals, Inc. Information

Contact top employees from Neurotech Pharmaceuticals, Inc.

Summary

Neurotech Pharmaceuticals, Inc. is a private company that has been in the industry for 30 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Richard Small. Its headquarters is located at Cumberland, Rhode Island, USA. The number of employees ranges from 1 to 25. The annual revenue of Neurotech Pharmaceuticals, Inc. varies between 100K and 5.0M. Total funding of the company - $50M. To connect with Neurotech Pharmaceuticals, Inc. employee register on SignalHire.

Industries

Biotechnology

Headquarters Location

Employees Size

100-200 employees

SIC Code

2836

DMA Code

Providence Metropolitan Area

Founded

1995

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Contact Neurotech Pharmaceuticals, Inc.

Organization Website

Phone Number

401-333-3880

Competitors

Founded
Type
Employees
Revenue
Funding
1987Public
Company
100 - 250 39.2M $158.2M
2006Public
Company
100 - 250 32.3M $188.9M
2011Public
Company
1 - 25 15M $266M
2005Public
Company
250 - 500 113M $580M
1948Public
Company
1.0K - 5.0K 682.4M $320.5M
2011Privately
Held
25 - 100 11.9M $59.2M

Employees Turnover 3 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Neurotech Pharmaceuticals, Inc. shows a diverse range of experience levels:
3% have been with the company for less than 1 year14% for 1–2 years7% for 3–4 years21% for 5–7 years10% for 8–10 years45% have over 11 years of service at Neurotech Pharmaceuticals, Inc.
Ex-employees positions
In Company
In New Company
Contact top employees from Neurotech Pharmaceuticals, Inc.
Jennifer Guemple BSN
Field Reimbursement Director
View
Jacob Patterson Esq
VP, Head Of Quality
View
Josh Stults
Key Account Manager
View
Nicole Johnson
Director Field Reimbursement
View
Sean
Associate Director of Data Governance and Compliance
View
Mike Bradley
Validation Manager
View
Ryan Duhe
Key Account Manager
View
Darren Fernandez
Key Account Manager
View
Rachel Renshaw
Director of Professional Engagement & Commercial Partnerships
View
Terry Henschen
Key Account Manager
View
Brandon George
Key Account Manager
View
Beth Marsh
Chief Commercial Officer (CCO)
View
Josh Gener
US Medical Affairs | Ophthalmology Senior MSL (West Coast)
View
Emmanuel Tagoe
QC Specialist
View
Roy Konyeaso
Head of Quality Control/Sr. Director of Quality Control
View
Julie Sousa
QA Principal
View
Travis Gors
Senior Director of Sales Training
View
Rex Gouin
Facilities Associate
View
Ashley Fernandez
Associate Director of Raw Materials
View
Andrew Tenney
Head of US Commercial Operations
View
Suzanne Gaddy
Executive Assistant to Executive Chairman of the Board of Directors, CEO and Office Management
View
David Coyne
Head of Commercial Finance
View
Paul Brannelly
Chief Financial Officer
View
Julie
Quality Assurance Supervisor (Operations)
View
Patricia Davis
Vice President Clinical Operations
View
Brennan Scott
Director Cell Therapy Manufacturing
View
Jay Deka
Commercial Insights and Analytics
View
Pariss Petersen
Director of Quality Operations
View
Samantha Dougherty
QC Manager, Raw Materials and Sample Management
View

FAQ

Neurotech Pharmaceuticals, Inc. operates in the Biotechnology industries. More details can be found on the official website: neurotechpharmaceuticals.com.
The headquarters of Neurotech Pharmaceuticals, Inc. are located in Cumberland, United States.
The current CEO of Neurotech Pharmaceuticals, Inc. is Richard Small
You can contact Neurotech Pharmaceuticals, Inc. by phone at 401-333-3880.
Neurotech Pharmaceuticals, Inc. currently employs 100-200 people.
Neurotech Pharmaceuticals, Inc.'s revenue is approximately 4M.
Well-known competitors of Neurotech Pharmaceuticals, Inc. include EyePoint, Ocular Therapeutix, Inc., Aerpio Pharmaceuticals and Aerie Pharmaceuticals.
BACK TO TOP